Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Use of corticosteroids in asthma and COPD patients with or without COVID-19
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Use of corticosteroids in asthma and COPD patients with or without COVID-19
Creator
Capstick, Toby
Hasan,
Kow, Chia
Merchant, Hamid
Syed, Shahzad
Tabish, Syed
Zaidi, Razi
Capstick, Syed
Hasan, Toby
Kow, Hamid
Merchant,
Tabish, Razi
Zaidi, Chia
Source
Elsevier; Medline; PMC
abstract
The potential detrimental effects of steroids on the immune system to fight viral infections had always been a concern for patients on long term steroids in chronic conditions. A recent warning from WHO on systemic corticosteroid use amid COVID-19 raised suspicion among public and healthcare professionals regarding the safety of steroid use during the SARS-CoV-2 pandemic. The corticosteroids (inhaled and oral) are commonly prescribed in the management of asthma and COPD patients and any unsolicited changes in medications use may lead to potentially severe exacerbations and risk patient lives. This article provides a critical review of clinical evidence and offers a detailed discussion on the safety and efficacy of corticosteroids in asthma and COPD patients, both with and without COVID-19.
has issue date
2020-05-26
(
xsd:dateTime
)
bibo:doi
10.1016/j.rmed.2020.106045
bibo:pmid
32843175
has license
no-cc
sha1sum (hex)
d9197446bb4d3f2e991d10dd7ff20512ddd698fa
schema:url
https://doi.org/10.1016/j.rmed.2020.106045
resource representing a document's title
Use of corticosteroids in asthma and COPD patients with or without COVID-19
has PubMed Central identifier
PMC7255263
has PubMed identifier
32843175
schema:publication
Respir Med
resource representing a document's body
covid:d9197446bb4d3f2e991d10dd7ff20512ddd698fa#body_text
is
schema:about
of
named entity 'This'
named entity 'COVID-19'
named entity 'severe'
named entity 'COVID-19'
named entity 'asthma'
named entity 'CLINICAL'
named entity 'PATIENTS'
named entity 'CONDITIONS'
named entity 'management'
named entity 'COPD'
named entity 'safety'
named entity 'corticosteroids'
named entity 'patients'
named entity 'corticosteroids'
named entity 'steroids'
named entity 'long term'
named entity 'chronic conditions'
named entity 'steroid'
named entity 'steroids'
named entity 'asthma'
named entity 'COVID'
named entity 'corticosteroids'
named entity 'asthma'
named entity 'article'
named entity 'SARS-CoV-1'
named entity 'asthma'
named entity 'COVID'
named entity '19, 20'
named entity 'confidence intervals'
named entity 'lower respiratory tract infection'
named entity 'asthma'
named entity 'COVID'
named entity 'COPD'
named entity 'respiratory infection'
named entity 'asthma'
named entity 'emergency treatment'
named entity 'IL-1'
named entity 'viral pneumonia'
named entity 'relapse'
named entity 'case report'
named entity 'COVID-19 pandemic'
named entity 'bronchodilator'
named entity 'mucus'
named entity 'COVID'
named entity 'inhaled corticosteroids'
named entity 'respiratory infection'
named entity 'systematic review'
named entity 'inhaler'
named entity 'allergic asthma'
named entity 'COPD'
named entity 'epidemiological studies'
named entity 'nebulised'
named entity 'diabetologists'
named entity 'asthma'
named entity 'Primary Care'
named entity 'asthma'
named entity 'lung function'
named entity 'nebulisation'
named entity 'COVID-19 infection'
named entity 'COViD'
named entity '95% confidence interval'
named entity 'biological drug'
named entity 'giant cell arteritis'
named entity 'inflammatory bowel disease'
named entity 'asthma'
named entity 'COPD'
named entity 'randomised trials'
named entity 'intravenously'
named entity 'medical data'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 7
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software